首页 > 最新文献

Gynecologie Obstetrique Fertilite & Senologie最新文献

英文 中文
Gestation pour autrui altruiste en France : contexte et perspectives [法国的利他代孕:背景与前景]。
IF 0.8 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.gofs.2024.02.001
Mikaël Agopiantz , Matthieu Dap , Guillaume Mougniotte , Charline Bertholdt , Olivier Morel
{"title":"Gestation pour autrui altruiste en France : contexte et perspectives","authors":"Mikaël Agopiantz , Matthieu Dap , Guillaume Mougniotte , Charline Bertholdt , Olivier Morel","doi":"10.1016/j.gofs.2024.02.001","DOIUrl":"10.1016/j.gofs.2024.02.001","url":null,"abstract":"","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 6","pages":"Pages 436-439"},"PeriodicalIF":0.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139716631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Les pièges de l’analyse dichotomique d’une variable biologique continue : l’exemple de la taille maternelle et du pronostic de l’accouchement d’un enfant de plus de 4,0 kg [生物连续变量二分法分析中的陷阱?关于产妇身高与体重超过 4.0 千克的新生儿的分娩]。
IF 0.8 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.gofs.2024.01.009
Jeremy Boujenah , Anne Wahnich , Diane Korb
{"title":"Les pièges de l’analyse dichotomique d’une variable biologique continue : l’exemple de la taille maternelle et du pronostic de l’accouchement d’un enfant de plus de 4,0 kg","authors":"Jeremy Boujenah , Anne Wahnich , Diane Korb","doi":"10.1016/j.gofs.2024.01.009","DOIUrl":"10.1016/j.gofs.2024.01.009","url":null,"abstract":"","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 6","pages":"Pages 425-426"},"PeriodicalIF":0.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139547758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mise en place du dépistage de l’infection congénitale à cytomégalovirus dans une maternité française de type 3 [在法国 3 型孕产妇中开展巨细胞病毒先天感染筛查]。
IF 0.8 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.gofs.2024.01.010
Perrine Coste-Mazeau , Magali Hamon , Élodie Ribot , Sébastien Hantz , Sophie Alain

Objectives

Congenital cytomegalovirus (CMV) infection is the most common congenital infection and the leading cause of infectious neurosensorial disability in newborns. We wanted to organize the management of women from the beginning of pregnancy allowing access to antenatal treatment with valaciclovir, recognized since 2020 as limiting materno-fetal transmission. To this end, we set up and evaluated the interest of systematic screening for CMV infection in our maternity. We wanted to organize care for women from the very start of pregnancy.

Methods

Retrospective and comparative descriptive study carried out at the CHRU de Limoges from July 2017 to December 2019 (targeted screening), then from January 2020 to June 2022, during which period we implemented systematized screening by iterative serologies at the 3rd, 6th, 8th months and before delivery. Our main evaluation criteria were the seroprevalence of CMV infection and the rate of congenital infection. We then described our cases of infection (primary or secondary) during pregnancy.

Results

CMV seroprevalence in our pregnant women increased significantly from 52.7% (779/1478 women screened) to 58.4% (3852/6599 women screened) between the 2 study periods (P = 0.04). We diagnosed 11 infections during the first part of the study vs. 27 during the second, with a significant increase in primary infections from 0.14% (9/6524 births) to 0.37% (24/6426 births) (P = 0.008). Only 3 secondary infections were diagnosed during the second study period. The rate of congenital infections remained stable between the 2 study periods (6 children/6524 = 0.09% vs. 8 children/6426 = 0.12%; P = 0.57).

Conclusion

Our results confirmed the interest of screening for CMV infection, while modifying the screening strategy we had initiated.

目的:先天性巨细胞病毒(CMV)感染是最常见的先天性感染,也是导致新生儿感染性神经感官残疾的主要原因。我们希望从怀孕之初就对妇女进行管理,允许她们在产前接受伐昔洛韦治疗,自 2020 年以来,伐昔洛韦已被公认为可以限制母婴传播。为此,我们在产科建立并评估了系统筛查巨细胞病毒感染的意义。方法:2017 年 7 月至 2019 年 12 月(目标筛查),2020 年 1 月至 2022 年 6 月,我们在利摩日中心医院进行了回顾性和比较性描述性研究,在此期间,我们通过在第 3、6、8 个月和分娩前反复检测血清来实施系统筛查。我们的主要评估标准是 CMV 感染的血清阳性率和先天感染率。然后,我们对孕期感染(原发性或继发性)的病例进行了描述:在两个研究期间,孕妇的 CMV 血清感染率从 52.7%(779/1478 名接受筛查的妇女)大幅上升至 58.4%(3852/6599 名接受筛查的妇女)(P=0.04)。在研究的第一阶段,我们诊断出 11 例感染,而在第二阶段则诊断出 27 例,原发性感染率从 0.14%(9/6524 例新生儿)显著上升至 0.37%(24/6426 例新生儿)(P=0.008)。在第二个研究期间,仅诊断出 3 例二次感染。先天性感染率在两个研究期间保持稳定(6/6524 =0.09% vs. 8/6426 =0.12%;p=0.57):我们的研究结果证实了对 CMV 感染进行筛查的意义,同时也修改了我们已经启动的筛查策略。
{"title":"Mise en place du dépistage de l’infection congénitale à cytomégalovirus dans une maternité française de type 3","authors":"Perrine Coste-Mazeau ,&nbsp;Magali Hamon ,&nbsp;Élodie Ribot ,&nbsp;Sébastien Hantz ,&nbsp;Sophie Alain","doi":"10.1016/j.gofs.2024.01.010","DOIUrl":"10.1016/j.gofs.2024.01.010","url":null,"abstract":"<div><h3>Objectives</h3><p>Congenital cytomegalovirus (CMV) infection is the most common congenital infection and the leading cause of infectious neurosensorial disability in newborns. We wanted to organize the management of women from the beginning of pregnancy allowing access to antenatal treatment with valaciclovir, recognized since 2020 as limiting materno-fetal transmission. To this end, we set up and evaluated the interest of systematic screening for CMV infection in our maternity. We wanted to organize care for women from the very start of pregnancy.</p></div><div><h3>Methods</h3><p>Retrospective and comparative descriptive study carried out at the <em>CHRU de Limoges</em> from July 2017 to December 2019 (targeted screening), then from January 2020 to June 2022, during which period we implemented systematized screening by iterative serologies at the 3rd, 6th, 8th months and before delivery. Our main evaluation criteria were the seroprevalence of CMV infection and the rate of congenital infection. We then described our cases of infection (primary or secondary) during pregnancy.</p></div><div><h3>Results</h3><p>CMV seroprevalence in our pregnant women increased significantly from 52.7% (779/1478 women screened) to 58.4% (3852/6599 women screened) between the 2 study periods (<em>P</em> <!-->=<!--> <!-->0.04). We diagnosed 11 infections during the first part of the study vs. 27 during the second, with a significant increase in primary infections from 0.14% (9/6524 births) to 0.37% (24/6426 births) (<em>P</em> <!-->=<!--> <!-->0.008). Only 3 secondary infections were diagnosed during the second study period. The rate of congenital infections remained stable between the 2 study periods (6 children/6524<!--> <!-->=<!--> <!-->0.09% vs. 8 children/6426<!--> <!-->=<!--> <!-->0.12%; <em>P</em> <!-->=<!--> <!-->0.57).</p></div><div><h3>Conclusion</h3><p>Our results confirmed the interest of screening for CMV infection, while modifying the screening strategy we had initiated.</p></div>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 6","pages":"Pages 403-409"},"PeriodicalIF":0.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139565258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccination contre la varicelle, grossesse et allaitement : un état des lieux [水痘疫苗接种、怀孕和母乳喂养:现状]。
IF 0.8 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.gofs.2024.01.012
Catherine Vauzelle , Elisabeth Elefant , Bénédicte Coulm , Mathilde Latour , Delphine Beghin , Benoît Marin

The varicella vaccine is recommended for women with no history of varicella who are planning to become pregnant, as well as for post-pregnancy women, to prevent the occurrence of this illness and its severe complications, especially an embryopathy, when it occurs in a pregnant woman (congenital varicella syndrome). This live attenuated vaccine should not be administered during pregnancy, nor in the month preceding it. However, when this occurs inadvertently, the data collected on the outcomes of exposed pregnancies, although few in women seronegative at the time of vaccination, allow to reassure the patients to date, as no congenital varicella syndrome has been reported to date following accidental vaccination in early pregnancy. On the other hand, during breastfeeding, a woman may be vaccinated if there is an expected short- or medium-term benefit (varicella exposure, planned pregnancy…).

建议计划怀孕的无水痘史妇女和怀孕后的妇女接种水痘疫苗,以预防水痘及其严重并发症的发 生,尤其是孕妇出现胚胎病(先天性水痘综合征)时。怀孕期间或怀孕前一个月都不应接种这种减毒活疫苗。不过,如果不慎发生这种情况,收集到的暴露妊娠的结果数据(尽管接种疫苗时血清反应阴性的妇女很少)可以让患者放心,因为迄今为止还没有在怀孕早期意外接种疫苗后出现先天性水痘综合症的报道。另一方面,在母乳喂养期间,如果有预期的短期或中期益处(水痘暴露、计划怀孕......),妇女可以接种疫苗。
{"title":"Vaccination contre la varicelle, grossesse et allaitement : un état des lieux","authors":"Catherine Vauzelle ,&nbsp;Elisabeth Elefant ,&nbsp;Bénédicte Coulm ,&nbsp;Mathilde Latour ,&nbsp;Delphine Beghin ,&nbsp;Benoît Marin","doi":"10.1016/j.gofs.2024.01.012","DOIUrl":"10.1016/j.gofs.2024.01.012","url":null,"abstract":"<div><p>The varicella vaccine is recommended for women with no history of varicella who are planning to become pregnant, as well as for post-pregnancy women, to prevent the occurrence of this illness and its severe complications, especially an embryopathy, when it occurs in a pregnant woman (congenital varicella syndrome). This live attenuated vaccine should not be administered during pregnancy, nor in the month preceding it. However, when this occurs inadvertently, the data collected on the outcomes of exposed pregnancies, although few in women seronegative at the time of vaccination, allow to reassure the patients to date, as no congenital varicella syndrome has been reported to date following accidental vaccination in early pregnancy. On the other hand, during breastfeeding, a woman may be vaccinated if there is an expected short- or medium-term benefit (varicella exposure, planned pregnancy…).</p></div>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 6","pages":"Pages 432-435"},"PeriodicalIF":0.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139681951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Développement d’un outil d’évaluation de l’anxiété de performance en obstétrique [开发产科绩效焦虑测量工具]。
IF 0.8 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.gofs.2024.01.007
Dio Andriamanjay , Pierre Castel , Claude D’Ercole , Florence Bretelle , Aubert Agostini , Julie Berbis , Julie Blanc

Objective

Developing a measuring tool for physician's performance anxiety during obstetrical procedures, as a self-administered questionnaire.

Methods

We used the Delphi method. First, we did a literature review to identify the items to submit for the first round. A panel of experts was asked to rate the relevance of items from one to six. For the first round of Delphi, items were retained if more than 70% of respondents assigned a five or six rating. Items were excluded if more than 70% of respondents assigned a one or two rating. All the other items, plus those suggested by the panel, were submitted to a second round of Delphi. The same item selection conditions were applied to the second round.

Results

The overall response rate to the Delphi was 79% (19 respondents). At the end of the first round, 14 items were consensually relevant, no item was consensually irrelevant. For the second round, the 18 items that did not find consensus and seven new items suggested by the experts in the first round were submitted. At the end of the second round, nine items were retained by consensus as relevant.

Conclusion

This study defined by consensus 23 items for a self-questionnaire to measure specific performance anxiety in obstetrics divided into five dimensions: perceived stress, assessment of the risk of complications, medico-legal risk, impact of the healthcare team and peers, self-confidence and decision-making confidence. We intend to validate this tool in real population.

目的开发一种测量产科过程中医生工作焦虑的工具,作为一种自填式问卷:我们采用了德尔菲法。首先,我们进行了文献综述,以确定第一轮提交的项目。然后请专家小组对项目的相关性进行评分,评分标准为一至六分。在第一轮德尔菲法中,如果超过 70% 的受访者给予 5 分或 6 分的评分,则保留该项目。如果超过 70% 的受访者给项目打 1 分或 2 分,则排除该项目。所有其他项目,加上小组建议的项目,都提交给第二轮德尔菲。第二轮的项目选择条件与第一轮相同:德尔菲法的总回复率为 79%(19 位受访者)。第一轮结束时,14 个项目一致认为相关,没有项目一致认为不相关。在第二轮中,提交了第一轮中未达成共识的 18 个项目和专家建议的 7 个新项目。第二轮结束时,9 个项目被一致认为是相关的:本研究以协商一致的方式确定了 23 个项目,用于测量产科特定绩效焦虑的自我问卷,分为五个维度:感知压力、并发症风险评估、医疗法律风险、医护团队和同行的影响、自信心和决策信心。我们打算在实际人群中验证这一工具。
{"title":"Développement d’un outil d’évaluation de l’anxiété de performance en obstétrique","authors":"Dio Andriamanjay ,&nbsp;Pierre Castel ,&nbsp;Claude D’Ercole ,&nbsp;Florence Bretelle ,&nbsp;Aubert Agostini ,&nbsp;Julie Berbis ,&nbsp;Julie Blanc","doi":"10.1016/j.gofs.2024.01.007","DOIUrl":"10.1016/j.gofs.2024.01.007","url":null,"abstract":"<div><h3>Objective</h3><p>Developing a measuring tool for physician's performance anxiety during obstetrical procedures, as a self-administered questionnaire.</p></div><div><h3>Methods</h3><p>We used the Delphi method. First, we did a literature review to identify the items to submit for the first round. A panel of experts was asked to rate the relevance of items from one to six. For the first round of Delphi, items were retained if more than 70% of respondents assigned a five or six rating. Items were excluded if more than 70% of respondents assigned a one or two rating. All the other items, plus those suggested by the panel, were submitted to a second round of Delphi. The same item selection conditions were applied to the second round.</p></div><div><h3>Results</h3><p>The overall response rate to the Delphi was 79% (19 respondents). At the end of the first round, 14 items were consensually relevant, no item was consensually irrelevant. For the second round, the 18 items that did not find consensus and seven new items suggested by the experts in the first round were submitted. At the end of the second round, nine items were retained by consensus as relevant.</p></div><div><h3>Conclusion</h3><p>This study defined by consensus 23 items for a self-questionnaire to measure specific performance anxiety in obstetrics divided into five dimensions: perceived stress, assessment of the risk of complications, medico-legal risk, impact of the healthcare team and peers, self-confidence and decision-making confidence. We intend to validate this tool in real population.</p></div>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 6","pages":"Pages 384-390"},"PeriodicalIF":0.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468718924000114/pdfft?md5=898766396e723d182e3fff741c0c498a&pid=1-s2.0-S2468718924000114-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139514166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oxytocine et neuroprotection en période néonatale : évidences conceptuelles et précliniques [催产素作为新生儿神经保护策略:概念和临床前证据]。
IF 0.8 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.gofs.2023.12.005
Olivier Baud , Marit Knoop
<div><h3>Objectif</h3><p>La prématurité et le retard de croissance utérin sont responsables de lésions cérébrales associées à l’apparition de troubles neurocognitifs et comportementaux chez plus de 9 millions d’enfants chaque année. Le bénéfice clinique de la plupart des stratégies pharmacologiques visant à prévenir les lésions cérébrales périnatales reste à confirmer. En revanche, l’enrichissement de l’environnement du nouveau-né induit des effets positifs sur la structure et la fonction du cerveau, influence les réponses hormonales du nouveau-né et semble avoir des conséquences neurocomportementales durables pendant la petite enfance et à l’âge adulte. L’ocytocine (OT), un neuropeptide libéré par l’hypothalamus, pourrait représenter la base hormonale de ces effets à long terme.</p></div><div><h3>Méthode</h3><p>Cette revue de la littérature fait le point sur les connaissances concernant l’effet de l’OT chez le nouveau-né et les données précliniques suggérant son effet neuroprotecteur.</p></div><div><h3>Résultats</h3><p>L’OT joue un rôle pendant la période périnatale, dans l’attachement parents-enfant et dans le comportement social. En outre, des études précliniques suggèrent fortement que l’OT endogène et synthétique est capable de réguler la réponse inflammatoire du système nerveux central en réponse aux situations de prématurité ou plus généralement d’agressions du cerveau en développement. L’effet à long terme de l’adminsitration d’OT synthétique au cours du travail est également abordé.</p></div><div><h3>Conclusion</h3><p>L’ensemble des données conceptuelles et expérimentales converge pour indiquer que l’OT serait un acteur clé dans la neuroprotection néonatale, notamment par la régulation de la neuroinflammation.</p></div><div><h3>Objective</h3><p>Prematurity and intra-uterine growth retardation are responsible for brain damage associated with various neurocognitive and behavioral disorders in more than 9 million children each year. Most pharmacological strategies aimed at preventing perinatal brain injury have not demonstrated substantial clinical benefits so far. In contrast, enrichment of the newborn's environment appears to have positive effects on brain structure and function, influences newborn hormonal responses, and has lasting neurobehavioral consequences during infancy and adulthood. Oxytocin (OT), a neuropeptide released by the hypothalamus, may represent the hormonal basis for these long-term effects.</p></div><div><h3>Method</h3><p>This review of the literature summarizes the knowledge concerning the effect of OT in the newborn and the preclinical data supporting its neuroprotective effect.</p></div><div><h3>Results</h3><p>OT plays a role during the perinatal period, in parent-child attachment and in social behavior. Furthermore, preclinical studies strongly suggest that endogenous and synthetic OT is capable of regulating the inflammatory response of the central nervous system in response to situations of prematurity or more g
目的:早产和宫内发育迟缓是造成脑损伤的罪魁祸首,每年有 900 多万儿童因此出现各种神经认知和行为障碍。迄今为止,大多数旨在预防围产期脑损伤的药物治疗策略并未显示出实质性的临床疗效。相比之下,丰富新生儿环境似乎对大脑结构和功能有积极影响,可影响新生儿荷尔蒙反应,并对婴儿期和成年期的神经行为产生持久影响。催产素(OT)是下丘脑释放的一种神经肽,可能是这些长期影响的激素基础:方法:这篇文献综述总结了有关催产素对新生儿影响的知识以及支持催产素神经保护作用的临床前数据:结果:OT 在围产期、亲子依恋和社会行为中发挥作用。此外,临床前研究强烈表明,内源性和合成 OT 能够调节中枢神经系统对早产情况或更普遍的对发育中大脑的损伤的炎症反应。本文还讨论了在分娩过程中服用合成 OT 的长期效果:结论:所有概念和实验数据都表明,OT 将成为新生儿神经保护的理想候选物质,特别是通过调节神经炎症。
{"title":"Oxytocine et neuroprotection en période néonatale : évidences conceptuelles et précliniques","authors":"Olivier Baud ,&nbsp;Marit Knoop","doi":"10.1016/j.gofs.2023.12.005","DOIUrl":"10.1016/j.gofs.2023.12.005","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objectif&lt;/h3&gt;&lt;p&gt;La prématurité et le retard de croissance utérin sont responsables de lésions cérébrales associées à l’apparition de troubles neurocognitifs et comportementaux chez plus de 9 millions d’enfants chaque année. Le bénéfice clinique de la plupart des stratégies pharmacologiques visant à prévenir les lésions cérébrales périnatales reste à confirmer. En revanche, l’enrichissement de l’environnement du nouveau-né induit des effets positifs sur la structure et la fonction du cerveau, influence les réponses hormonales du nouveau-né et semble avoir des conséquences neurocomportementales durables pendant la petite enfance et à l’âge adulte. L’ocytocine (OT), un neuropeptide libéré par l’hypothalamus, pourrait représenter la base hormonale de ces effets à long terme.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Méthode&lt;/h3&gt;&lt;p&gt;Cette revue de la littérature fait le point sur les connaissances concernant l’effet de l’OT chez le nouveau-né et les données précliniques suggérant son effet neuroprotecteur.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Résultats&lt;/h3&gt;&lt;p&gt;L’OT joue un rôle pendant la période périnatale, dans l’attachement parents-enfant et dans le comportement social. En outre, des études précliniques suggèrent fortement que l’OT endogène et synthétique est capable de réguler la réponse inflammatoire du système nerveux central en réponse aux situations de prématurité ou plus généralement d’agressions du cerveau en développement. L’effet à long terme de l’adminsitration d’OT synthétique au cours du travail est également abordé.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;p&gt;L’ensemble des données conceptuelles et expérimentales converge pour indiquer que l’OT serait un acteur clé dans la neuroprotection néonatale, notamment par la régulation de la neuroinflammation.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;p&gt;Prematurity and intra-uterine growth retardation are responsible for brain damage associated with various neurocognitive and behavioral disorders in more than 9 million children each year. Most pharmacological strategies aimed at preventing perinatal brain injury have not demonstrated substantial clinical benefits so far. In contrast, enrichment of the newborn's environment appears to have positive effects on brain structure and function, influences newborn hormonal responses, and has lasting neurobehavioral consequences during infancy and adulthood. Oxytocin (OT), a neuropeptide released by the hypothalamus, may represent the hormonal basis for these long-term effects.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Method&lt;/h3&gt;&lt;p&gt;This review of the literature summarizes the knowledge concerning the effect of OT in the newborn and the preclinical data supporting its neuroprotective effect.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;p&gt;OT plays a role during the perinatal period, in parent-child attachment and in social behavior. Furthermore, preclinical studies strongly suggest that endogenous and synthetic OT is capable of regulating the inflammatory response of the central nervous system in response to situations of prematurity or more g","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 6","pages":"Pages 418-424"},"PeriodicalIF":0.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S246871892300257X/pdfft?md5=30ced80001e5d926c8aa3d21fea46062&pid=1-s2.0-S246871892300257X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139038182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
L’accouchement des femmes enceintes de jumeaux : les enseignements de l’étude nationale observationnelle prospective comparative JUMODA [双胞胎的分娩:来自全国观察性前瞻性比较研究JUMODA的经验教训]。
IF 0.8 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.gofs.2023.11.005
Thomas Schmitz , François Goffinet

Objectives

To summerize the results of the JUMODA study (JUmeaux MODe d’Accouchement) on the planned mode of delivery of twin pregnancy and the management of second twin delivery.

Methods

JUMODA was a national observational prospective comparative study that took place between february 2014 and march 2015 in 176 french maternity units performing more than 1500 deliveries per year. Its main objectives were the comparison of neonatal and maternal morbidity according to the planned mode of delivery and the determination of the managements of second twin delivery associated with the best neonatal outcomes. To control for potential confounding factors and indication biases, statistical analyses comprized multivariate logistic regressions and matching on propensity scores.

Results

The JUMODA study recruited 8823 women with twin delivery at or beyond 22 weeks of gestation. For twin pregnancies with a cephalic first twin at 32 weeks of gestation and beyond, severe neonatal morbidity was higher in the planned cesarean (150/2908 (5.2 %) than in the planned vaginal delivery group (199/8922 (2.2 %), aOR 1.56, 95 % CI 1.19-2.04). Increased neonatal morbidity in the planned cesarean delivery group was explained by higher severe morbidity in neonates born preterm (aOR 1.64, 95 % CI 1.13-2.39, for deliveries between 32+0 and 34+6 weeks of gestation, aOR 2.04, 95 % CI 1.22-3.41, for deliveries between 35+0 SA and 36+6 weeks of gestation) but not in neonates born at term (aOR 1.19, 95 % CI 0.58-2.44). In comparison with planned cesarean delivery, planned vaginal delivery was not associated with increased severe neonatal morbidity in case of breech presenting first twin after 32 weeks of gestation or with decreased survival witout severe neonatal morbidity in case of delivery before 32 weeks of gestation whatever the first twin presentation. In comparison with planned vaginal delivery, planned cesarean delivery was associated with increased severe maternal morbidity only in women aged 35 and higher. Delivery of non cephalic second twin was associated with similar severe neonatal morbidity rate than delivery of cephalic second twin. Finally, in case of cephalic second twin, internal version followed by total breech extraction was associated with less cesarean for the second twin but with higher severe neonatal morbidity in case of preterm birth in comparison with pushing efforts, ocytocin perfusion and artificial rupture of membranes.

Conclusions

Planned vaginal delivery is the planned mode of delivery to encourage for the majority of pregnant women with twins, whatever first twin presentation and gestational age at delivery. No management of cephalic second twin appears better than an other, its choice will rest on obstetrician preferences.

目的:总结JUMODA (Jumeaux MODe d'Accouchement)关于双胎妊娠计划分娩方式和二胎分娩管理的研究结果。方法:JUMODA是一项全国性的观察性前瞻性比较研究,于2014年2月至2015年3月在176个法国产科单位进行,每年分娩超过1500次。其主要目的是根据计划分娩方式比较新生儿和产妇发病率,并确定与最佳新生儿结局相关的第二胎分娩管理。为了控制潜在的混杂因素和指征偏差,统计分析包括多元逻辑回归和倾向评分匹配。结果:JUMODA研究招募了8823名怀孕22周或以上的双胎分娩妇女。对于孕32周及以上首胎为头胎的双胎妊娠,计划剖宫产组(150/2908(5.2%))的新生儿严重发病率高于计划阴道分娩组(199/8922 (2.2%),aOR为1.56,95% CI为1.19-2.04)。计划剖宫产组新生儿发病率增加的原因是早产新生儿的严重发病率较高(aOR 1.64, 95% CI 1.13-2.39,妊娠32+0周至34+6周分娩,aOR 2.04, 95% CI 1.22-3.41,妊娠35+0周至36+6周分娩),但足月新生儿没有这种情况(aOR 1.19, 95% CI 0.58-2.44)。与计划剖宫产相比,计划阴道分娩与妊娠32周后臀位出现第一个双胞胎的严重新生儿发病率增加无关,也与妊娠32周前分娩的生存率降低无关,无论第一个双胞胎出现与否。与计划阴道分娩相比,计划剖宫产仅在35岁及以上的妇女中与严重产妇发病率增加有关。非头二胎分娩与头二胎分娩的严重新生儿发病率相似。最后,对于头位的二胎,与推胎、催产素灌注和人工破膜术相比,内翻后全臀抽出与二胎剖宫产较少相关,但在早产情况下,新生儿严重发病率更高。结论:计划阴道分娩是大多数双胞胎孕妇的计划分娩方式,无论第一个双胞胎的出现和分娩时的胎龄如何。没有任何一种治疗方法比另一种更好,其选择将取决于产科医生的偏好。
{"title":"L’accouchement des femmes enceintes de jumeaux : les enseignements de l’étude nationale observationnelle prospective comparative JUMODA","authors":"Thomas Schmitz ,&nbsp;François Goffinet","doi":"10.1016/j.gofs.2023.11.005","DOIUrl":"10.1016/j.gofs.2023.11.005","url":null,"abstract":"<div><h3>Objectives</h3><p>To summerize the results of the JUMODA study (JUmeaux MODe d’Accouchement) on the planned mode of delivery of twin pregnancy and the management of second twin delivery.</p></div><div><h3>Methods</h3><p>JUMODA was a national observational prospective comparative study that took place between february 2014 and march 2015 in 176 french maternity units performing more than 1500 deliveries per year. Its main objectives were the comparison of neonatal and maternal morbidity according to the planned mode of delivery and the determination of the managements of second twin delivery associated with the best neonatal outcomes. To control for potential confounding factors and indication biases, statistical analyses comprized multivariate logistic regressions and matching on propensity scores.</p></div><div><h3>Results</h3><p>The JUMODA study recruited 8823 women with twin delivery at or beyond 22 weeks of gestation. For twin pregnancies with a cephalic first twin at 32 weeks of gestation and beyond, severe neonatal morbidity was higher in the planned cesarean (150/2908 (5.2 %) than in the planned vaginal delivery group (199/8922 (2.2 %), aOR 1.56, 95 % CI 1.19-2.04). Increased neonatal morbidity in the planned cesarean delivery group was explained by higher severe morbidity in neonates born preterm (aOR 1.64, 95 % CI 1.13-2.39, for deliveries between 32<sup>+0</sup> and 34<sup>+6</sup> weeks of gestation, aOR 2.04, 95 % CI 1.22-3.41, for deliveries between 35<sup>+0</sup> SA and 36<sup>+6</sup> weeks of gestation) but not in neonates born at term (aOR 1.19, 95 % CI 0.58-2.44). In comparison with planned cesarean delivery, planned vaginal delivery was not associated with increased severe neonatal morbidity in case of breech presenting first twin after 32 weeks of gestation or with decreased survival witout severe neonatal morbidity in case of delivery before 32 weeks of gestation whatever the first twin presentation. In comparison with planned vaginal delivery, planned cesarean delivery was associated with increased severe maternal morbidity only in women aged 35 and higher. Delivery of non cephalic second twin was associated with similar severe neonatal morbidity rate than delivery of cephalic second twin. Finally, in case of cephalic second twin, internal version followed by total breech extraction was associated with less cesarean for the second twin but with higher severe neonatal morbidity in case of preterm birth in comparison with pushing efforts, ocytocin perfusion and artificial rupture of membranes.</p></div><div><h3>Conclusions</h3><p>Planned vaginal delivery is the planned mode of delivery to encourage for the majority of pregnant women with twins, whatever first twin presentation and gestational age at delivery. No management of cephalic second twin appears better than an other, its choice will rest on obstetrician preferences.</p></div>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 6","pages":"Pages 410-417"},"PeriodicalIF":0.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138300720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conséquences de la réforme du 3e cycle des études médicales sur l’accès à la formation en médecine de la reproduction 第三周期医学研究改革对生殖医学培训机会的影响
IF 0.8 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.gofs.2024.05.003
Geoffroy Robin (Coordonnateur national de la FST Médecine et Biologie de la Reproduction – Andrologie)
{"title":"Conséquences de la réforme du 3e cycle des études médicales sur l’accès à la formation en médecine de la reproduction","authors":"Geoffroy Robin (Coordonnateur national de la FST Médecine et Biologie de la Reproduction – Andrologie)","doi":"10.1016/j.gofs.2024.05.003","DOIUrl":"https://doi.org/10.1016/j.gofs.2024.05.003","url":null,"abstract":"","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 6","pages":"Pages 381-383"},"PeriodicalIF":0.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141294570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La cholestase gravidique : pour une vision holistique de la femme. À propos des examens complémentaires lors du diagnostic [妊娠期肝内胆汁淤积症:从妇女的角度看问题。关于超声波筛查]。
IF 0.8 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.gofs.2024.02.023
Jeremy Boujenah
{"title":"La cholestase gravidique : pour une vision holistique de la femme. À propos des examens complémentaires lors du diagnostic","authors":"Jeremy Boujenah","doi":"10.1016/j.gofs.2024.02.023","DOIUrl":"10.1016/j.gofs.2024.02.023","url":null,"abstract":"","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 6","pages":"Page 427"},"PeriodicalIF":0.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139974756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Applicabilité de l’Adnex score dans la prédiction de la malignité des kystes ovariens [Adnex 评分在预测卵巢囊肿恶性程度中的适用性]。
IF 0.8 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.gofs.2023.12.001
Karima Mekni , Meriam Baba , Ines Haddad , Monia Aaraar , Oumayma Mejri , Chiraz ElFekih

Objective

Ovarian cancer screening is a difficult problem due to the anatomy of the ovaries. Only histology allows a definite diagnosis. Our objective was to study the contribution of the Adnex score in the histological characterization of adnexal images for adequate management.

Methods

It was a retrospective, mono-center, descriptive and analytical. Sixty-five patients were included, those operated for an ovarian cyst and meeting the Adnex criteria: clinical, ultrasound and laboratory.

Results

The mean age of the patients was 38.6 years. They were nulliparous in 43 % of cases, and only four had a history of operation on ovarian cyst. Abdominal pelvic pain was the most frequent reason for consultation in 48 % of cases. An abdominopelvic mass was found on abdominal examination in 11 % of cases. Pelvic ultrasound made it possible to objectify the presence of an ovarian mass in all cases, with an average size of 79.66 mm and a reassuring appearance in 66 % of cases. The calculation of the Adnex score was done in all patients preoperatively, for a 10 % cut-off, the model showed an 86 % chance of benignity for tumors proven to be histologically benign. The main route of entry was laparoscopy, in 61 % of cases. The treatment was in most cases conservative consisting essentially of a cystectomy.

Conclusion

The Adnex score discriminated well between benign and malignant masses, allowing for a better diagnosis preoperatively. It thus deserves its applicability in the clinical setting.

目的 :由于卵巢的解剖结构,卵巢癌筛查是一个难题。只有通过组织学检查才能明确诊断。我们的目的是研究 Adnex 评分在附件图像的组织学特征描述中的贡献,以便进行适当的管理:这是一项回顾性、单中心、描述性和分析性研究。结果:患者的平均年龄为 38 岁,平均年龄为 50 岁,平均年龄为 60 岁:结果:患者的平均年龄为 38.6 岁。结果:患者的平均年龄为 38.6 岁,43% 的患者为无子宫,只有 4 名患者曾接受过卵巢囊肿手术。腹盆腔疼痛是最常见的就诊原因,占 48%。11%的病例在腹部检查时发现腹盆腔肿块。盆腔超声检查可确定所有病例中都存在卵巢肿块,平均大小为 79.66 毫米,66% 的病例外观令人欣慰。所有患者术前都进行了Adnex评分计算,以10%为临界值,该模型显示,经组织学证实为良性的肿瘤良性几率为86%。61%的病例的主要入院途径是腹腔镜手术。大多数病例的治疗方法是保守治疗,主要包括膀胱切除术:结论:Adnex评分能很好地区分良性和恶性肿块,使术前诊断更加准确。结论:Adnex评分能很好地区分良性肿块和恶性肿块,从而更好地进行术前诊断,因此值得应用于临床。
{"title":"Applicabilité de l’Adnex score dans la prédiction de la malignité des kystes ovariens","authors":"Karima Mekni ,&nbsp;Meriam Baba ,&nbsp;Ines Haddad ,&nbsp;Monia Aaraar ,&nbsp;Oumayma Mejri ,&nbsp;Chiraz ElFekih","doi":"10.1016/j.gofs.2023.12.001","DOIUrl":"10.1016/j.gofs.2023.12.001","url":null,"abstract":"<div><h3>Objective</h3><p>Ovarian cancer screening is a difficult problem due to the anatomy of the ovaries. Only histology allows a definite diagnosis. Our objective was to study the contribution of the Adnex score in the histological characterization of adnexal images for adequate management.</p></div><div><h3>Methods</h3><p>It was a retrospective, mono-center, descriptive and analytical. Sixty-five patients were included, those operated for an ovarian cyst and meeting the Adnex criteria: clinical, ultrasound and laboratory.</p></div><div><h3>Results</h3><p>The mean age of the patients was 38.6 years. They were nulliparous in 43 % of cases, and only four had a history of operation on ovarian cyst. Abdominal pelvic pain was the most frequent reason for consultation in 48 % of cases. An abdominopelvic mass was found on abdominal examination in 11 % of cases. Pelvic ultrasound made it possible to objectify the presence of an ovarian mass in all cases, with an average size of 79.66<!--> <!-->mm and a reassuring appearance in 66 % of cases. The calculation of the Adnex score was done in all patients preoperatively, for a 10 % cut-off, the model showed an 86 % chance of benignity for tumors proven to be histologically benign. The main route of entry was laparoscopy, in 61 % of cases. The treatment was in most cases conservative consisting essentially of a cystectomy.</p></div><div><h3>Conclusion</h3><p>The Adnex score discriminated well between benign and malignant masses, allowing for a better diagnosis preoperatively. It thus deserves its applicability in the clinical setting.</p></div>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 6","pages":"Pages 398-402"},"PeriodicalIF":0.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138812318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gynecologie Obstetrique Fertilite & Senologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1